Oral Presentation

[28V08-pm] 免疫・生体防御／ウイルス／抗ウイルス薬

Sun. Mar 28, 2021 3:27 PM - 5:27 PM [Room V08] Oral Presentation 8 (Online)

座長：南保明日香（長崎大）、浦田秀造（長崎大感染症共同研究拠点）

+Add all to schedule

3:27 PM - 3:39 PM

[28V08-pm11] Search for the mechanism of rubella virus infection in human cells using a CRISPR-Cas9 knockout screen.

○Minami Hama³, Mayuko Yagi³, Yurie Nakashima³, Daiki Kanbayashi², Takako Kurata², Kosuke Yusa¹, Jun Komano³ (1. Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan., 2. Department of Infectious Diseases, Osaka Institute of Public Health., 3. Department of Microbiology and Infection Control, Osaka University of Pharmaceutical Sciences, Osaka, Japan.)

3:39 PM - 3:51 PM

[28V08-pm12] Structural insight into the interaction of the Sendai virus C protein with Alix stimulating the ESCRT-dependent viral budding

○Kosuke Oda¹, Yasuyuki Matoba², Masanori Sugiyama¹, Takemasa Sakaguchi¹ (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2. Fac. Pharm., Yasuda Women’s Univ.)

3:51 PM - 4:03 PM

[28V08-pm13S] Fluorescence sialidase probe for the visualization and detection of sialidase

○Takahiro Shindo¹, Yuuki Kurebayashi¹, Tadanobu Takahashi¹, Tadamune Otsubo², Tomomi Miura¹, Momoko Tanabe¹, Kouki Amano¹, Akira Minami¹, Kiyoshi Ikeda², Takashi Suzuki¹ (1. Grad. Sch. Pharm Sci., Univ. of Shizuoka., 2. Grad. Sch. Pharm Sci., Hiroshima international Univ.)

4:03 PM - 4:15 PM

[28V08-pm14S] Analysis of the low-pH stability in the neuraminidase(NA) of influenza A(H1N1)pdm09 virus

○AYUMI OHARA¹, YUKI KUREBAYASI¹, Otani Nagisa¹, TADANOBU TAKAHASI¹, TAKASI SUZUKI¹ (1. Sch. Pharm. Sci., Univ, of Shizuoka)

4:15 PM - 4:27 PM

[28V08-pm15S] Regulation of influenza type A virus infection by a novel type of inhibitory peptide against CaMKII

○Shinichiro Hama¹, Miho Takahashi¹, Jumpei Omi², Kiyotaka Nishikawa¹ (1. Grad. Sch. Biomed. Sci., Doshisha Univ., 2. Grad. Sch. Pha., Tokyo Univ.)

4:27 PM - 4:39 PM

[28V08-pm16] The screening of anti-COVID-19 drugs from inhibitors of lipid metabolizing enzymes

○Yasuhiro Hayashi¹, Kiyoto Tsuchiya², Mizuki Yamamoto³, Yoko Nemoto-Sasaki¹, Kazuya Tanigawa¹, Kotaro Hama¹, Jun-ichiro Inoue⁴, Atsushi Yamashita¹ (1. Faculty of Pharma-Science, Teikyo University, 2. National Center of Global Health and Medicine, 3. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, 4. Senior Professor Office, The University of Tokyo)

4:39 PM - 4:51 PM

[28V08-pm17] APOBEC3A regulates HIV latency and interferon-stimulated gene expression

○Manabu Taura^1,2, Akiko Iwasaki² (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. Sch. Med., Yale Univ. )

4:51 PM - 5:03 PM

[28V08-pm18S] HMGB1-TLR4 signal enhances proliferation and immunosuppressive function of MDSCs

○Zhiqi Xie¹, Daisuke Okuzaki^2,3, Naoki Okada¹, Masashi Tachibana^1,4 (1. Grad. Sch. Pharm., Osaka Univ., 2. IFReC, Osaka Univ. , 3. RIMD, Osaka Univ., 4. MEIC. Osaka Univ.)

5:03 PM - 5:15 PM

[28V08-pm19S] Induction of antigen-specific CD8-positive T cells using originally created dendritic cell-targeting peptides.

○Matsuda Teppei^1,2,3, Yasuo Yoshioka^1,2,3,4,5 (1. Grad. Sch. Pharma. Sci., Osaka Univ., 2. Institute for Open and Transdisciplinary Research Initiatives., 3. Research Institute for Microbial Diseases , Osaka Univ., 4. BIKEN Co., Ltd., Osaka Univ., 5. Global Center for medical Engineering and information., Osaka Univ.)

5:15 PM - 5:27 PM

[28V08-pm20] Analysis of role of STAP-1 in pathogenesis of autoimmune hepatitis

○Jun-ichi Kashiwakura¹, Yuto Sasaki¹, Kota Kagohashi¹, Tadashi Matsuda¹ (1. Grad. Sch. Pharm. Sci, Hokkaido Univ.)

Session information